Report Highlights
The U.S. market for amino acids represents 20% of the global market with nearly $1.6 billion (in 2011), and is likely to exceed $1.8 billion by 2016, a compound annual growth rate (CAGR) of 2.8% between 2011 and 2016.
Report Scope
This technical/market report outlines the properties of the 20 commercial essential amino acids that are delineated in the genetic code, current and future uses, technology, and their manufacturers. This report focuses on three commercial amino acid markets: animal feed supplements, flavoring and nutritional additives for human food, and specialty uses including medical, therapeutic, research, and industrial applications. Feed and food applications offer steady growth opportunities to their manufacturers and their use will continue to grow both as a result of population increases and an overall increase in the worldwide standard of living.
Analyst Credentials
Jon Evans has been involved in business development and research for the medical industry since 1984. Mr. Evans’ career includes 4 years as a diagnostic systems sales representative and over 15 years in market research and strategy analysis with Fortune 500 clients. He has developed expertise in assessing the unique business development challenges facing firms in the medical industry and designing strategies to optimize market performance. Mr. Evans received a BS in biology from Rutgers University in 1983, and an MBA in business analysis from San Francisco State University in 1989.
Report Highlights
- The global market for protein drugs is expected to increase from an estimated $1.1 billion in 2008 to $1.3 billion in 2013, a compound annual growth rate (CAGR) of 2.9%.
- Amino acids used as flavorants generated an estimated $510.4 million in 2008. This segment should reach $588.2 million in 2013, for a CAGR of 2.9%.
- The animal feeds segment was worth $472.4 million in 2008. This is expected to reach $526.4 million in 2013, for a CAGR of 2.2%.
Report Highlights
-
The U.S. amino acid market will likely surpass $1.5 billion by 2005. Annual growth should be 3.3% on average per year (AAGR) while individual amino acids could see growth spurts.
-
With anticipated 2005 U.S. annual sales exceeding $900 million, the animal feed supplements market will remain the largest market category for amino acids.
-
The four amino acids used as food flavoring agents will account for more than $450 million in 2005.
-
Sales of specialty amino acids used for feeding solutions, pharmaceuticals, biotechnology and medical applications, are expected to rise at an AAGR of 6.5% to about $150 million in 2005.
Report Highlights
-
Twenty amino acids go into making up the commercial amino acid market. This group plays many roles in a variety of fields including foods, animal feeds, cosmetics, medicines, and biotechnology as well as some industrial applications. In dollar terms, the most important current uses are in the animal feed industries and human food uses.
-
The three primary categories of commercial amino acids in the U.S. represented a billion-dollar market for the first time in 1999. The U.S. amino acid market should again surpass the billion-dollar mark in 2000 as factories across the nation and around the world increase production and sales to meet a growing demand. The U.S. amino acid market will likely surpass $1.5 billion by 2005.
-
With anticipated 2000 U.S. annual sales exceeding $800 million, the animal feed supplements market represents the largest market category for amino acids. Export sales of amino acid animal feed supplements will exceed $250 million.
Related Reports
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More